Related Experiment Video
Updated: May 5, 2026
Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
Published on: May 30, 2019
Cas12a is competitive for gene editing in the malaria parasites
Shijie Yang1, Yiming Wei1, Elvis Quansah2
1The Second Clinical Medical College, Anhui Medical University, Hefei, 230032, People's Republic of China.
Abstract:
Malaria, caused by the Plasmodium parasites, has always been one of the worst infectious diseases that threaten human health, making it necessary for us to study the genetic function and physiological mechanisms of Plasmodium parasites from the molecular level to find more effective ways of addressing the increasingly pressing threat. The CRISPR (Clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated protein) is an RNA-guided adaptive immune system, which has been extensively developed and used as a genome editing tool in many organisms, including Plasmodium parasites. However, due to the physiological characteristics and special genomic characteristics of Plasmodium parasites, most of the tools currently used for genome editing of Plasmodium parasites have not met expectations. CRISPR-Cas12a (also known as Cpf1), one of the CRISPR-Cas systems, has attracted considerable attention because of its characteristics of being used for biological diagnosis and multiple genome editing. Recent studies have shown that its unique properties fit the genetic makeup of Plasmodium parasites making it a promising tool for gene editing in these parasites. In this review, we have summarized the relevant content of the Cas12 family, especially the frequently used Cas12a, its advantages for gene editing, and the application prospects in Plasmodium parasites.
Insights
CRISPR-Cas12a offers a promising solution for Plasmodium parasite gene editing, overcoming limitations of current tools. This review explores its advantages for malaria research and control.
Area of Science:
- Molecular Biology
- Genetics
- Parasitology
Background:
- Malaria, caused by Plasmodium parasites, remains a significant global health threat, necessitating advanced genetic research.
- CRISPR-Cas systems are powerful genome editing tools, but their application in Plasmodium is limited by parasite-specific characteristics.
- Existing genome editing tools have not fully met the demands for studying Plasmodium genetics.
Purpose of the Study:
- To review the Cas12 family, focusing on Cas12a's potential for Plasmodium gene editing.
- To highlight the advantages of CRISPR-Cas12a for overcoming challenges in Plasmodium genetic manipulation.
- To explore the future applications of Cas12a in malaria research and therapeutic development.
Main Methods:
- Literature review of CRISPR-Cas systems, particularly Cas12a.
- Analysis of Cas12a's unique properties and their suitability for Plasmodium genetics.
- Examination of current limitations in Plasmodium genome editing.
Main Results:
- CRISPR-Cas12a exhibits unique characteristics beneficial for genome editing.
- Its properties align well with the genetic makeup of Plasmodium parasites.
- Cas12a shows promise in overcoming existing challenges in Plasmodium gene editing.
Conclusions:
- CRISPR-Cas12a is a highly promising tool for advancing Plasmodium parasite research.
- Its application could lead to more effective strategies for malaria control.
- Further research into Cas12a applications in Plasmodium is warranted.
More Related Videos
09:25CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
